V
Veracyte, Inc. (VCYT)
NGM – Real vaqt narxi. Valyuta: USD
39.56
-0.14 (-0.35%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
39.56
-0.14 (-0.35%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Veracyte, Inc. Amerika Qo'shma Shtatlari va xalqaro miqyosda diagnostika kompaniyasi sifatida faoliyat yuritadi. Kompaniya qalqonsimon bez tugunlari uchun Afirma Genomic Sequencing Classifier; prostata saratonini tashxislash uchun Decipher Prostate Genomic Classifiers; siydik pufagi saratonini tashxislash uchun Decipher Bladder Genomic Classifier; ko'krak bezi saratonini tashxislash uchun Prosigna Breast Cancer Assay; va o'pka saratonini tashxislash uchun Percepta Nasal Swab Testni taklif etadi. Shuningdek, u nCounter tahlil tizimi xizmatlarini taqdim etadi. Kompaniya ilgari Calderome, Inc. nomi bilan tanilgan va 2008 yil mart oyida Veracyte, Inc. nomini o'zgartirgan. Veracyte, Inc. 2006 yilda tashkil etilgan va uning shtab-kvartirasi Kaliforniyaning Janubiy San-Fransisko shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. John Leite Ph.D. | Global Chief Commercial Officer |
| Dr. Keith Gligorich Ph.D. | Senior Vice President of Global Operations |
| Dr. Kevin Richard Haas Ph.D. | Chief Development and Technology Officer |
| Dr. Phillip G. Febbo M.D. | Chief Scientific & Medical Officer |
| Mr. Jonathan Wygant | VP & Chief Accounting Officer |
| Mr. Marc A. Stapley | CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-06 | 10-Q | vcyt-20260331.htm |
| 2026-05-05 | 8-K | vcyt-20260505.htm |
| 2026-04-22 | DEFA14A | vcyt-proxynotice2026xdefa1.htm |
| 2026-03-16 | 8-K | vcyt-20260313.htm |
| 2026-02-26 | 10-K | vcyt-20251231.htm |
| 2026-02-25 | 8-K | vcyt-20260225.htm |
| 2026-01-12 | 8-K | vcyt-20260111.htm |
| 2025-11-05 | 10-Q | vcyt-20250930.htm |
| 2025-11-04 | 8-K | vcyt-20251104.htm |
| 2025-08-07 | 10-Q | vcyt-20250630.htm |
| Mr. Steven French | Senior VP & Chief Information Officer |
| Ms. Annie McGuire | Executive VP, General Counsel & Head of Market Access |
| Ms. Karen Possemato | Senior Vice President of Corporate Marketing, Communications & Commercial Operations |
| Ms. Rebecca Chambers | Executive VP & CFO |